|
Source – Druginfozone - According to an article in MIMS (March 2006), Konakion MM paediatric is now licensed for use intramuscularly (following discontinuation of Konakion Neonatal) for the treatment of vitamin K deficiency bleeding in healthy neonates of 36 weeks gestation or older.
However, healthcare professionals are advised to exercise caution to avoid dosage errors with Konakion MM paediatric as it is 5 times
stronger than Konakion Neonatal. The recommended dose is 0.1mL by Intramuscular injection at or shortly after birth, and not 0.5mL as previously used for the Konakion Neonatal formulation
For more information go to: http://www.druginfozone.nhs.uk/record%20viewing/viewRecord.aspx?id=561580
Prepared by Susan Wileman Medicines Information Technician
Date of Preparation: 7th March 2006
|
